Phase III Study of Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

NCT00967850 Phase 3 COMPLETED

The purpose of this study is to determine the efficacy and safety of intravitreal injections of bevacizumab in High Myopia´s choroidal neovascularization versus the standard treatment of Photodynamic therapy.

Details

Lead sponsor	Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
Phase	Phase 3
Status	COMPLETED
Enrolment	56
Start date	2008-04
Completion	2011-06

Conditions

• Myopia
• Choroidal Neovascularization

Interventions

• Intravitreal Injection
• Photodynamic Therapy (Visudyne)

Primary outcomes

• Improvement in Visual Acuity assessed by ETDRS — Every month during first year - Every three months during the second year

Countries

Spain